Introduction

For CRG, 2013 was a year of recovery and a year of consolidation. Recovery, because, despite the crisis, signs of improvement started to appear, and consolidation because the CRG continued working and striving to produce first-rate science and remain one of the leading centres in both Europe and the world, in the area biomedicine and life sciences.

The SCImago Institution Rankings (SIR) World Report 2013, covering the years 2007-2011, classifies the CRG in 9th position (according to the Q1 indicator, health sector) out of over 2,740 research institutions around the world. In Europe only three other research centres in the health sector have a higher Q1 indicator. These results contribute to motivating the CRG researchers and, at the same time, remind all CRG staff that they should continue to work hard to maintain and improve all these standards of excellence.

The number and quality of the papers published by CRG scientists have not stopped increasing. In 2013, 197¹ papers were published in peer-reviewed journals with an average impact factor of 8.836, and 108 seminars were held by top-level invited speakers. The media picked up many of these activities, and the CRG hit the news (newspapers, radio, TV) on 578 occasions.

At the end of October, we celebrated our 12th Annual Symposium, entitled “BCN2: Biological Control Networks in Barcelona”.  The network has become an icon for systems biology and a flexible central framework for understanding a wide range of biological questions, from gene regulation and cell biology to neuroscience and evolution. The meeting brought together top biologists and theoreticians from around the world to present new views and discuss the latest developments. Throughout the diverse fields presented, the underlying universal aspects of networks, as well as the field-specific features, were explored through talks, open discussions and a poster session (http://2013symposium.crg.eu/).

Finally some of our young and senior scientists obtained awards and honours in recognition of the excellence of their science during the year. Ben Lehner received the Eppendorf Young Investigator Award 2013, Johannes Jaeger was awarded the Society for Experimental Biology President’s Medal, Roderic Guigó was given the City of Barcelona Award 2012, Salvador Aznar-Benitah was awarded the Metastasis Research Prize 2013 of the Beug Foundation, and Vivek Malhotra received the Merck Award from the American Society of Biochemistry and Molecular Biology (ASBMB). Additionally, Toni Gabaldón and Marc Marti-Renom were appointed ICREA Research Professors, Pedro Carvalho was selected as an EMBO Young Investigator, Luciano Di Croce was elected EMBO Member, and Mara Dierssen was appointed President of the Spanish Society for Neurosciences (SENC).


[1] This includes: articles and reviews

12th CRG Symposium, BCN2: Biological Control Networks in Barcelona
12th CRG Symposium, BCN2: Biological Control Networks in Barcelona
Eppendorf Young Investigator Award 2013
Eppendorf Young Investigator Award 2013